tiprankstipranks
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
US Market

Y-Mabs Therapeutics (YMAB) Technical Analysis

Compare
521 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Y-Mabs Therapeutics’s (YMAB) Moving Averages Convergence Divergence (MACD) indicator is -0.42, suggesting Y-Mabs Therapeutics is a Sell.
Y-Mabs Therapeutics’s (YMAB) 20-Day exponential moving average is 6.31, while Y-Mabs Therapeutics’s (YMAB) share price is $6.24, making it a Sell.
Y-Mabs Therapeutics’s (YMAB) 50-Day exponential moving average is 7.65, while Y-Mabs Therapeutics’s (YMAB) share price is $6.24, making it a Sell.

Y-Mabs Therapeutics (YMAB) Pivot Points

Feb 17, 2025, 01:49 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.34
5.60
5.88
6.14
6.42
6.68
6.96
Fibonacci
5.60
5.80
5.93
6.14
6.34
6.47
6.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Y-Mabs Therapeutics (YMAB) Moving Averages

Feb 17, 2025, 01:49 AM
Period
Simple
Exponential
MA5
6.05Buy
6.11Buy
MA10
6.05Buy
6.10Buy
MA20
6.10Buy
6.31Sell
MA50
7.56Sell
7.65Sell
MA100
10.51Sell
9.42Sell
MA200
11.61Sell
11.17Sell
Y-Mabs Therapeutics’s (YMAB) 10-Day exponential moving average is 6.10, while Y-Mabs Therapeutics’s (YMAB) share price is $6.24, making it a Buy.
Y-Mabs Therapeutics’s (YMAB) 100-Day exponential moving average is 9.42, while Y-Mabs Therapeutics’s (YMAB) share price is $6.24, making it a Sell.
Y-Mabs Therapeutics’s (YMAB) stock price is $6.24 and Y-Mabs Therapeutics’s (YMAB) 50-day simple moving average is 7.56, creating a Sell signal.
Y-Mabs Therapeutics’s (YMAB) stock price is $6.24 and Y-Mabs Therapeutics’s (YMAB) 100-day simple moving average is 10.51, creating a Sell signal.
Y-Mabs Therapeutics’s (YMAB) stock price is $6.24 and Y-Mabs Therapeutics’s (YMAB) 200-day simple moving average is 11.61, creating a Sell signal.

Y-Mabs Therapeutics (YMAB) Technical Indicators

Feb 17, 2025, 01:49 AM
Name
Value
Implied Action
RSI (14)
42.21
Neutral
STOCH (9,6)
58.38
Neutral
STOCHRSI (14)
44.32
Neutral
MACD (12,26)
-0.42
Sell
ADX (14)
24.33
Neutral
Williams %R
-39.05
Buy
CCI (14)
134.76
Sell
ATR (14)
0.43
-
Ultimate Oscillator
44.39
Neutral
ROC
1.46
Buy
Y-Mabs Therapeutics’s (YMAB) Relative Strength Index (RSI) is 42.21, creating a Neutral signal.
Y-Mabs Therapeutics’s (YMAB) Trend Strength Indicator (ADX) is 24.33, creating a Neutral signal.
Y-Mabs Therapeutics’s (YMAB) Commodity Channel Index (CCI) is 134.76, creating a Sell signal.
Y-Mabs Therapeutics’s (YMAB) Price Rate of Change (ROC) is 1.46, creating a Buy signal.

FAQ

Is YMAB a Buy, Hold, or Sell?
Based on YMAB’s technical indicators, YMAB is a Hold.
    What is YMAB’s RSI (14)?
    YMAB’s RSI (14) is 42.21, which suggests YMAB is a Neutral.
      What is YMAB’s MACD?
      YMAB’s MACD is -0.42, which suggests YMAB is a Sell.
        What is YMAB’s 5-day moving average?
        YMAB’s 5-day moving average is 6.05, which suggests YMAB is a Buy.
          What is YMAB’s 20-day moving average?
          YMAB 20-day moving average is 6.10, which suggests YMAB is a Buy.
            What is YMAB’s 50-day moving average?
            YMAB’s 50-day moving average is 7.56, which suggests YMAB is a Sell.
              What is YMAB’s 200-day moving average?
              YMAB’s 200-day moving average is 11.61, which suggests YMAB is a Sell.
                What is YMAB’s Williams % R (14)?
                YMAB’s Williams % R (14) is -39.05, which suggests YMAB is a Buy.
                  What is YMAB’s CCI (14)?
                  YMAB’s CCI (14) is 134.76, which suggests YMAB is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis